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Summary In spite of its reputation as a tumour marker, little is known about the function of carcinoem-
bryonic antigen (CEA). We examined the mRNA expression of CEA and NCA in 26 gastric and 14 colorectal
cancers together with adjacent morphologically normal mucosae. There was no significant difference between
the CEA mRNA levels of colorectal cancer and adjacent mucosa, whereas the CEA mRNA levels were
significantly elevated in gastric cancer compared with normal gastric mucosa. The expression of NCA, on the
other hand, was more cancer-specific and was significantly up-regulated in both gastric and colorectal cancers
compared with the corresponding normal mucosae. No correlation was found between the mRNA level and
plasma CEA value. No significant up-regulation was recognised in the node positive cancer, cancer with
distant metastasis, or the metastatic tissues themselves. Marked diversity in the degree of differentiation in
gastric cancer tissues, however, resulted in varied expression of the CEA gene family, compared with the
constantly high expression found in colorectal cancer. Further analysis revealed significant up-regulation of
NCA in well and moderately differentiated gastric cancers over poorly differentiated cancers, suggesting that
NCA might have roles in differentiation.
Carcinoembryonic antigen (CEA), a membrane glycoprotein
with a molecular mass of about 180,000, originally described
in 1965 as a tumour-associated colon cancer antigen (Gold &
Freeman, 1965), is now widely used in clinical practice as a
tumour marker. Several other closely related glycoproteins
have been isolated from various human tissues and faeces
(Kuroki, 1981; Zimmerman, 1987; Cournoyer, 1988), consti-
tuting what are now called the CEA related antigens.
The cDNA clones for CEA (Zimmerman, 1987; Oikawa,
1987; Kamarck, 1987; Beauchemin, 1987) and NCA
(Neumaier, 1988; Tawaragi, 1988; Cournoyer, 1988) have
been isolated and characterised. These led to several studies
on the expression of CEA related antigens in surgically
resected specimen. The expression of CEA mRNA in colon
cancer and normal colon mucosa have been proved by
Northern blot analysis (Cournoyer, 1988; Sato, 1988;
Hinoda, 1991), while its localisation throughout the cyto-
plasm of adenomas and carcinomas has been detected by in
situ hybridisation (Higashide, 1990). NCA, also detected in
colon cancer tissues (Cournoyer, 1988; Chi, 1991), was found
to be the predominant member of the CEA family in normal
lung and most of lung cancer tissues (Hasegawa, 1993). The
expression of CEA gene family in gastric cancer and normal
gastric mucosa, however, has not been examined in detail to
date.
Several attempts have been made in vivo and in vitro to
assess the function of the CEA molecules. Adhesion
molecules have provided insights into tumour invasion and
metastasis (Liotta, 1991). CEA is known to be one of the
adhesion molecules and has been reported to cause homo-
typic aggregation of colorectal cancer cells (Benchimol,
1989), while a systemic injection of CEA has been reported
to enhance metastasis to the liver in an experimental model
in athymic nude mice (Hobstetter, 1989). These facts impli-
cate some association of CEA with metastasis. On the other
hand, induction of cell differentiation has been known to
result in enhanced CEA mRNA levels in vitro (Toribara,
1989; Hauck, 1991) and these reports implicate association of
CEA with differentiation.
The true function of CEA in vivo, however, has not been
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elucidated to date. We report here the analysis of mRNA
expression of CEA and NCA in surgically resected gastro-
intestinal cancer tissues and adjacent normal mucosae by
Northern blot analysis, and provide some new insights that
might provide clues to the functions of CEA.
Materials and methods
Tissuepreparation
The following tissues were obtained during surgery in
Nagoya University Hospital, Nagoya, Japan, Komaki
Municipal Hospital, Komaki City, Japan, and Nakatsugawa
Municipal Hospital, Nakatsugawa City, Japan; 26 human
gastric cancer tissues (18 with matching adjacent mor-
phologically normal gastric mucosae, four with matching
metastatic lymph nodes, two with matching liver metastases),
three normal gastric mucosae from the patients with early
gastric cancer (Table I), and 14 colorectal cancer tissues (ten
with matching adjacent mucosae, two with matching nodal
metastases, and one with matching liver metastasis; Table II).
They were frozen in liquid nitrogen within 15 min of resec-
tion and stored at - 80°C until use.
Cell line
A gastric cancer cell line MKN45 was obtained from the
Japanese Cancer Research Resources Bank and cultured in
RPMI 1640 medium supplemented with 10% foetal calf
serum.
cDNA probes
The cDNA probe for CEA used in this study, CEA3, is a
Pvu 1I-digested DNA fragment of the pCEA 55-2 clone
(Oikawa, 1987). It includes the first internal domain
homologous to the internal domain of NCA cDNA (Figure
1). Therefore, it detects a 2.9-kilobase transcript correspond-
ing to NCA as well as the 4.2 and 3.5-kilobase transcripts
corresponding to CEA (Sato, 1988). The NCA-specific probe
(Figure 1) is an EcoRI-digested DNA fragment of the 3'-
untranslated region of NCA clone 15 (Tawaragi et al., 1988).
A human beta actin probe (Nakajima-Iijima et al., 1985) was
used as an internal control.
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Table I The clinical and histopathological classifications plasma CEA values, and CEA and NCA mRNA levels in
patients with gastric cancer
TNM
classification Plasma CEA mRNAd NCA mRNAd
Case0 T pN M Histologyb CEAC N Ca H L N Ca H L
1 1 2 1 Well diff. 2.2 14 27 4 51
2 3 2 0 Moderately diff. 0.1 8 91 0 39
3 1 2 1 Papillary 2.7 0 4 2 16 5
4 3 0 0 Papillary 2.0 8 66 5 71
5 1 2 0 Poorly diff. 4 3
6 2 1 0 Moderately diff. 96 44
7 1 0 0 6 0
8 1 0 0 17
9 1 1 0 Papillary 5 8 0 15
10 3 0 0 Poorly diff. 1.8 2 4 0 0 0 0
11 3 0 1 Moderately diff. 1.4 9 3
12 2 1 0 Moderately diff. 16.2 24 56
13 3 1 0 Poorly diff. 0.8 2 21 0 7
14 4 2 0 Moderately diff. 49.3 7 23 43 0 0
15 3 2 1 Poorly diff. 4.2 3 5 2 0 1
16 4 2 1 Moderately diff. 1.5 5 1 6 2
17 2 2 0 Moderately diff. 3.0 15 14 60 58
18 2 1 0 Poorly diff. 0 0 0 0
19 3 2 0 Well diff. 1.5 12 3
20 2 0 0 Poorly diff. 2.0 0 0
21 3 1 0 Well diff. 2.7 56 123
22 3 0 1 Poorly diff. 1.5 8 31 0 36
23 3 0 0 Moderately diff. 0.5 2 2 0 12
24 3 2 1 Signet cell ca. 3.0 0 14 0 47
25 3 2 1 Moderately diff. 0 38 0 20
26 2 2 0 Moderately diff. 1.9 20 93 0 136
27 2 2 0 Moderately diff. 5 36 13 49
28 3 2 0 Poorly diff. 0.8 0 32 0 43
29 1 0 0 0 0
30 2 0 0 Well diff. 0 7 0 2
'Case numbers correspond to those in Figure 2. bThe histopathological classification based on the degree of
differentiation was performed according to The General Rules for the Gastric Cancer Study (Japanese Research Society
for Gastric Cancer). cPlasma CEA values were evaluated within a few days before the surgical resection (ngml-1).
dmRNA levels of CEA and NCA are expressed in relation to the intensities of their expression in MKN45 designated as
100. Abbreviations: N = normal mucosa, Ca = cancer tissue, H = hepatic metastasis, L = lymph node metastasis.
Table II The clinical and histopathological classifications plasma CEA values, and CEA
patients with colorectal cancer
and NCA mRNA levels in
TNM
classification Plasma CEA mRNAd NCA mRNAd
Case0 T pN M Histologyb CEAC N Ca H L N Ca H L
1 4 0 0 Moderately diff. 10.1 87 46 43 188
2 3 2 0 Moderately diff. 1.3 6 59 0 56
3 3 2 1 Poorly diff. 34.1 26 35 37 40
4 3 2 0 Moderately diff. 34.9 66 83 18 55
5 3 0 0 Well diff. 2.9 88 91 86 29
6 3 2 1 Moderately diff. 1500 81 83
7 2 0 0 Moderately diff. 2.5 20 118 40 31
8 3 0 0 Mucinous adenoca 4.4 33 45
9 3 1 0 Moderately diff. 6.0 75 198 14 50
10 2 0 0 Well diff. 5.2 56 45 2 2
11 2 0 0 Moderately diff. 7.3 83 79 22 112
12 2 0 0 Moderately diff. 52.7 41 27 20 31
13 2 0 0 Moderately diff. 1.0 83 166 29 97
14 2 1 0 Moderately diff. 1.8 86 90 28 42
'Case numbers correspond to those in Figure 2. bThe histopathological classification based on the degree of
differentiation was performed according to The General Rules for Clinical and Pathological Studies on cancer of Colon,
Rectum, and Anus (Japanese Research Society for Cancer of Colon and Rectum). cPlasma CEA values were evaluated
within a few days before the surgical resection (ngml-'). dmRNA levels ofCEA and NCA are expressed in relation to the
intensities of their expression in MKN45 designated as 100. Abbreviations are similar to those in Table I.
RNA extraction and Northern blot analysis
Total RNA was extracted from the surgical specimen and the
cell line by the procedure of Chomczynski (Chomczynski &
Sacchi, 1987). Ten micrograms of each RNA preparation was
subjected to electrophoretic separation using 1% agarose gels
containing 1.IM formaldehyde and transferred to Hybond-N
nylon membranes (Amersham).
Hybridisation with cDNA probes
Detection of transcripts with 32P-labelled cDNA probes
(Multiprime labelling system, Amersham, UK) was per-
formed by hybridisation for 18 h at 42°C in 5 x SSPE,
5 x Denhardt's solution (1 x Denhardt's solution is 0.02%
Ficoll, 0.02% polyvinylpyrrolidone, and 0.02% bovine serum
albumin), 50% formamide, 150 micro gml1' of heat-132 Y. KODERA etal.
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Figure 1 CEA and NCA cDNA probes used in the present
study. The CEA probe includes the first of the three repetitive
internal domains highly homologous with the NCA domain, and
cross-hybridises with NCA, resulting in a 2.9Kb transcript
together with the 4.2 Kb and 3.5 Kb transcripts corresponding to
CEA. The NCA probe derived from the 3'-untranslated region is
specific for NCA.
denatured salmon testis DNA, 10% dextran sulphate, 0.5%
SDS, and 106cpmml-1 of radioactive probe. Filters were
washed to a final stringency of 0.1 x SSC, 0.1 x SDS for
30 min at room temperature (1 x SSC is composed of
0.15 M NaCl and 15 mM sodium citrate) and autoradio-
graphed at - 70°C using Fuji RK film (Fuji Photo Film,
Kanagawa, Japan).
Densitometric analysis ofthe hybridisation signals
Fujix BAS 2000 Imaging Analyzer (Fuji Photo Film,
Kanagawa, Japan) was utilised for the densitometric analysis
of the 3.5-kb bands for CEA and 2.9-kb bands for NCA.
The intensity of the CEA and NCA bands of the positive
control, MKN45, included in each membrane, was deter-
mined to be 100 and intensities of the rest of the specimen
were expressed in relation to the positive control.
the operation. The clinical stages, histopathological
classifications and plasma CEA values are summarised in
Tables I and II.
Statistics
The Mann-Whitney test was performed for comparison of
the non-parametrically distributed mRNA levels between
different groups of specimen. Pearson's correlation coefficient
was calculated between the mRNA levels and plasma values
of CEA. Matched Wilcoxon test was performed for the
comparison of mRNA levels between the metastatic tissues
and their matching primary lesions.
Results
CEA and NCA mRNA levels in gastric and colon cancer
tissues and normal mucosae
The Northern blot analysis using the CEA and NCA cDNA
probes revealed bands corresponding to CEA at 4.2 and
3.5-kb and a band corresponding to NCA at 2.9-kb in almost
all specimens of gastric and colorectal malignancies (Figure 2
and 3). The number beneath each lane corresponds to the
case number in Tables I and II.
There was, however, a significant difference (U = 53.5,
P<0.0005) between the CEA mRNA levels in adenocar-
cinomas of stomach (n = 27) and colon (n = 14) as quanti-
tated by the imaging analyser (Figure 4); the former being
weaker than the latter. No significant difference in NCA gene
expression on the other hand, was detected between the two
groups (U = 95, P> 0.1).
Although the mRNA levels of CEA in gastric cancer speci-
mens (n = 27) were apt to be variable as discussed later, they
were significantly (U = 111, P<0.0005) elevated compared
with the mRNA levels in normal gastric mucosae (n = 22).
CEA mRNA expression was, however, weakly but distinctly
detected in some of the morphologically normal gastric
mucosa. CEA gene expression was almost invariably high in
normal colon mucosae (n = 11), and no statistically
significant difference (U = 61, P = 0.4) was found between
these and the mRNA levels in colorectal cancer specimens
(n= 14).
NCA expression (Figure 4) proved to be more specific to
cancerous tissues than that of CEA. It was detected in most
colon cancer specimens, and there was a significant difference
(U = 22.5, P<0.05) in the mRNA levels between colorectal
cancer (n = 12) and normal colon mucosae (n= 10). The
NCA expression in the normal gastric mucosae (n = 20) was
also significantly weaker (U = 26, P<0.0005) than the gas-
tric cancer tissues (n = 26), often too weak to be detected.
Staging andhistological classification
Staging was performed in accordance with The General
Rules for TNM classification (International Union Against
Cancer). Tissue specimens were promptly fixed in 10% for-
maldehyde, embedded in paraffin, and stained with hema-
toxylin and eosin. Tumour differentiation and degree of
invasion were examined by the pathologists and histo-
pathological classification was performed according to The
General Rules for the Gastric Cancer Study (Japanese
Research Society for Gastric Cancer, Kanehara Shuppan,
Tokyo, Japan), and The General Rules for Clinical and
Pathological Studies on Cancer of Colon, Rectum and Anus
(Japanese Research Society for Cancer of Colon and Rec-
tum, Kanehara Shuppan, Tokyo, Japan).
Plasma CEA values
The plasma CEA values of the patients were evaluated by a
commercial assay kit (Wako Pure Chemical Industries,
Osaka, Japan, cut-off value; 5 ngml-') a few days prior to
CEA gene expression andplasma CEA value
There was a lack of correlation between the gene expression
in malignant tissues and the plasma CEA values both in
gastric (r = - 0.056, P = 0.80) and colorectal (r=-0.021,
P = 0.94) cancer.
CEA gene expression and metastasis
In gastric cancer, no significant overexpression of CEA was
observed (U = 27.5, P = 0.37 between pNO and pNl, and
U = 34, P = 0.29 between pNO and pN2) between cancer
tissues with clinically detectable nodal metastasis (pNl:n = 6,
and pN2:n = 14) and those without (pNO:n = 7). The same
result (U = 68, P = 0.70) came from comparison between
gastric cancer tissues with distant metastasis (n = 8) and
those without (n = 19).
In colon cancer, too, the comparison of CEA gene expres-
sion between node positive (n = 6) and node negative (n = 8)
cancer tissues (U = 26, P = 0.75), and cancer tissues with
distant metastasis (n = 2) and those without (n = 12, U = 7,CEA AND NCA EXPRESSION IN GASTROINTESTINAL CANCER
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Figure 2 Northern blot analyses of CEA and NCA in surgical specimen from the patients with gastric cancer. Hybridisation with
CEA and cDNA results in three bands; the bands at 4.2 Kb and 3.5 Kb correspond to CEA while the band at 2.9 Kb is the result
of cross-hybridisation with NCA. Some of the bands not detected by exposure of 5-6 h appear by longer exposure. Hybridisation
with NCA cDNA specifically detects NCA transcript at 2.9 Kb. Beta actin was used as an internal control. The case numbers
correspond to the numbers in Table I. N stands for normal gastric mucosa, Ca for gastric cancer tissue, L for nodal metastasis, and
H for liver metastasis, respectively.
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Figure 3 Northern blot analyses of CEA and NCA in surgical specimens from patients with colorectal cancer. The bands detected
are identical to those described in the legend of Figure 2. The case numbers correspond to the numbers in Table II. The
abbreviations are similar to those in Figure 2.
P = 0.44) resulted in no difference of statistical tatic tissues and their matching primary lesions (n = 9).
significance. significant overexpression of the CEA gene was dete(
There was no significant difference either in NCA gene (P = 0.71) in the metastatic tissues.
expression between cancer tissues with nodal or distant
metastasis and those without both in gastric and colon CEA and NCA mRNA levels and histological classification
cancers.
CEA mRNA levels in some metastatic tissues have also There was an interesting correlation between CEA gene
been quantitated (Tables I and II). The matched Wilcoxon pression and pathological degree of differentiation in gas
test was performed between CEA gene expression in metas- cancer specimens (Figure 5). There was a tendency for x
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Figure 4 Left: The expression of CEA mRNAs in gastric
mucosae (n = 22), gastric cancer specimen (n = 27), colorectal
mucosae (n= 11), and colorectal cancer specimen (n = 14). The
intensity of the major 3.5 Kb band of the cell line MKN45,
determined by densitometric analysis with Fujix BAS2000 Imag-
ing Analyzer was designated as 100, and the expression of the
rest of the specimens were expressed in relation to MKN45. The
bars denote mean + s.d. Right: The expression of NCA mRNAs
in gastric mucosae (n = 20), gastric cancer tissues (n = 26), col-
orectal mucosae (n = 10), and colorectal cancer specimens
(n = 12). The intensity of the 2.9 Kb transcript of the cell line
MKN45 was designated as 100. The bars denote mean + s.d.
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Figure 5 The CEA and NCA mRNA levels (relative to those in
MKN45 as described in the legend of Figures 4 and 5) of the
gastric cancer tissues are shown in relation to the his-
topathological classification. The abbreviation por stands for
poorly differentiated adenocarcinoma (n = 7), mod for moderately
differentiated adenocarcinoma (n = 11) and well for well
differentiated adenocarcinoma (n = 4), respectively.
and moderately differentiated gastric cancers (n = 15) to
exceed the poorly differentiated cancers (n = 8) in CEA gene
expression although the probability was calculated to be of
borderline statistical significance (U = 35,P = 0.055). A
significant difference (U = 23,P = 0.024), though, was
observed between the NCA gene expression of well or
moderately differentiated cancers (n = 14) and poorly
differentiated cancers (n = 8).
Discussion
CEA, one of the most widely used of the tumour markers in
the diagnosis of colon cancer, has also been used in the
management of gastric cancer. However, although the gene
expression of the CEA-related gene family has been exten-
sively examined using clinical samples of colon and lung
cancer, gene expression in gastric cancer and gastric mucosa
has not yet been evaluated in detail.
In our series of Northern blot analyses, CEA gene expres-
sion of varied levels has been recognised in gastric cancer
tissues. Expression was significantly weaker compared with
the almost invariable overexpression found in colon cancer,
but it still exceeded the mRNA levels in normal gastric
mucosae which were faint in most and not detected in seven
cases. However, distinct expression of CEA mRNA was evi-
dent in some samples of the normal mucosae, including that
of case 8, a morphologically normal mucosa derived from a
patient with an early gastric cancer.
The mRNA levels of NCA in colon cancer have been
reported to be significantly elevated relative to the normal
mucosa (Chi, 1991) but the same results are now obtained
with gastric cancer. Such altered expression implicates NCA
as a more tumour-specific, if less organ-specific, tumour
marker, provided the NCA specific antibody not cross-
reacting with CEA is made available for the assay
system.
On evaluating the contribution of CEA overexpression to
metastasis, only the concomittant metastases found before or
at the time of operation were taken into consideration in this
study. Further periods of observation might allow the growth
and detection as recurrences of micrometastases in the
patients that we now diagnose as metastasis-free, and the
results could then be different. At the moment, however,
CEA was not found to be overexpressed in tumours with
nodal or distant metastases compared with those without.
Results such as those of case 3 or 11 in gastric cancer cast
doubts to the role of CEA in some cases of metastasis
formation, in spite of the encouraging in vivo study described
earlier (Hostetter, 1988).
The total lack of correlation between the plasma CEA and
CEA gene expression deserves some considerations. The
plasma value is known to correlate with the pattern of
immunostaining performed with the CEA monoclonal
antibody in colon cancer specimens (Hamada, 1985). Normal
colon mucosa exhibits an apical pattern of staining with low
plasma CEA values while moderately differentiated car-
cinomas exhibit a cytoplasmic pattern, sometimes with distri-
bution of CEA in the stroma, and result in high plasma CEA
values. Our study, however, demonstrated abundant CEA
gene expression in normal colon mucosa that is not signifi-
cantly lower compared with the expression in cancer tissue.
Nor was the CEA gene expression in the metastatic tissue
strikingly overexpressed compared with the primary lesion.
The overwhelming amount of normal colon mucosa in rela-
tion to the volume of cancerous tissue even in patients with
large tumours and evidence of metastasis, then, makes it
difficult to account for the 10- to 1000-fold elevation in
serum CEA values as observed in some patients, solely from
the point of view of the CEA gene expression. Some post-
transcriptional mechanism as suggested by the pattern of
immunostaining could underlie the mechanism of serum
CEA elevation.
Cellular differentiation induced by sodium butyrate
(Toribara, 1989) and gamma-interferon (Hauck, 1991), wasCEA AND NCA EXPRESSION IN GASTROINTESTINAL CANCER 135
reported to enhance CEA and NCA mRNA levels in human
colon cancer cell lines. The levels of CEA released from the
apical membranes into the medium rose in time-dependent
manner when a colon cancer cell line, HT29-D4 was induced
to differentiate by substituting galactose for glucose (Fantini,
1989). Whether the induction of CEA and NCA is the cause
or the result of the differentiation is unknown, but our results
concerning the expression of the CEA family and histopatho-
logical classification of gastric cancer samples seem to coin-
cide with these studies. Gastric cancers often exhibit a
chaotic mixture of portions with different degrees of
differentiation, and pathologists are required to select the
tissue type which they find is predominant on which to base
their histopathological diagnosis. This perhaps is one of the
reasons for the relatively large variation in mRNA expression
among specimens of the same histopathological diagnosis.
Significant differences in expression of NCA mRNA were
nevertheless observed between poorly and well or moderately
differentiated adenocarcinomas. One of the reasons for the
almost invariable detection of CEA mRNA in colon cancer
might then be that poorly differentiated adenocarcinomas are
relatively rare in colon, moderately to well differentiated
cancers being the predominant histological types found in
colorectal region. The only poorly differentiated colon cancer
among our specimen (case 3), indeed, was shown to express a
relatively low CEA mRNA level.
It is interesting to note that the expression of another
much investigated adhesion molecule, E-cadherin, is known
to correlate with differentiation in squamous cell carcinoma
of head and neck (Schipper, 1991) although the correlation is
less clear in gastric cancer (Shimoyama, 1991). Further
studies, though, will be needed to assess whether the CEA
family, too, contributes to differentiation through its function
as an adhesion molecule.
In conclusion, we postulate that (1) CEA mRNA level in
gastric cancer is detectable but significantly lower than that
of colon cancer, (2) the NCA mRNA is consistently overexp-
ressed relative to normal mucosa both in gastric and colon
cancer, (3) gene expression of CEA in cancer tissue does not
correlate directly with serum CEA value in a patient and (4)
association of the CEA family with differentiation has been
demonstrated in gastric cancer specimens, although further
studies will be needed to elucidate the true mechanism under-
lying this phenomenon.
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